2 insiders at Cencora, Inc. (COR) reported open-market stock purchases totaling $2,310,426 in recent weeks, according to filings with the U.S. Securities and Exchange Commission. The largest reported purchase came from DURCAN DERMOT MARK (director), who acquired 4,000 shares at $274.19 on June 18, 2026.
Source: SEC Form 4. Option grants and tax-withholding sales are excluded.
| Date | Insider | Role | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-06-22 | Tyler Lauren M | director | 550 | $270.23 | $148,626 | SEC Form 4 |
| 2026-06-18 | DURCAN DERMOT MARK | director | 4,000 | $274.19 | $1,096,760 | SEC Form 4 |
| 2026-05-28 | DURCAN DERMOT MARK | director | 4,000 | $266.26 | $1,065,040 | SEC Form 4 |
Cencora, Inc. is a Healthcare company in the Medical - Distribution industry. It carried a market capitalization of about $55.3B, with shares trading near $284.47.
This article is automated factual reporting of public SEC filings, for informational purposes only. It is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security, and reflects no opinion on the company. Figures are drawn from filings believed reliable but are not guaranteed. Always verify against the primary SEC filing and consult a licensed professional. Investing can lose value, up to total loss.